Clinical Trial Update: Clinical Study of First-line Treatment of Small Cell Lung Cancer (SCLC) With Anlotinib Hydrochloride [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating first-line treatment of small cell lung cancer with anlotinib hydrochloride.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Small Cell Lung Cancer

Drugs mentioned

• Anlotinib hydrochloride (anlotinib)

Snippet

Sponsor: Chifeng Municipal Hospital | Conditions: Small Cell Lung Cancer | Phase 4 | Status: UNKNOWN